RE: HG-CT-1 proves itself day by day20 Oct 2025 02:47
This, bored is... funny af.
Soms nut job starts a thread about how he's trolled avacta out the blue, I step in and give ACTUAL ways to troll it better and you lot crying saying im talking about,, avacta!! Haha
Then JHFH to his credit once again tries to de escalate it all but instead of saying dont, dont deramp other shares. And leave it there which would have ended it. He goes on to say how hemo is less risky than avacta and hemo as more upside.
So.i correct him and once again, you lot crying cos im, talking about, avacta haha you couldn't make this up. All there in black and white.
Hemo has some great science and what I do like is the low share count. The car t is safe 100% otherwise it wouldn't be approved for pediatrics by FDA. 3 adults treated and do far so good. We dont know that much about its efficacy though you guys can cry all you like but, much more time and data is needed.
I was hoping for the trial to accelerate after p3 was given all clear after all this is what vlad said would happen with new manufacturing process but here we are over 1 month since p3 had all clear and nothing. Silence. Only 3 patients data to review with supposedly clean safety profiles yet its taking more than a month to give the ok, come on. We're is the urgency. We're is the drive, where is the plan ffs.
Need to get a move, on. Im seeing a commercial deal pushed fo Q2 at this rate and unfortunately we will need extra cash by Q1 from where somewhere.